Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

8-K - Current report

Form Type: 8-K

Filing Date: 2015-05-05

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2015-04-30

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2015-04-29

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2015-04-27

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2015-04-17

View Filing

S-3 - Registration statement under Securities Act of 1933

Form Type: S-3

Filing Date: 2015-04-17

View Filing

ARS [Paper] - Annual Report to Security Holders

Form Type: ARS

Filing Date: 2015-04-15

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2015-04-07

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2015-03-13

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2015-02-19

View Filing